These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20601643)

  • 1. Current therapies and new strategies for the management of Alzheimer's disease.
    Aderinwale OG; Ernst HW; Mousa SA
    Am J Alzheimers Dis Other Demen; 2010 Aug; 25(5):414-24. PubMed ID: 20601643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in the development of new drugs in Alzheimer's disease.
    Piau A; Nourhashémi F; Hein C; Caillaud C; Vellas B
    J Nutr Health Aging; 2011 Jan; 15(1):45-57. PubMed ID: 21267520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.
    Singh YP; Rai H; Singh G; Singh GK; Mishra S; Kumar S; Srikrishna S; Modi G
    Eur J Med Chem; 2021 Apr; 215():113278. PubMed ID: 33662757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.
    Angelopoulou E; Piperi C
    Neuromolecular Med; 2019 Sep; 21(3):227-238. PubMed ID: 31313064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on treatment and prevention strategies for Alzheimer's disease.
    Neugroschl J; Sano M
    Curr Neurol Neurosci Rep; 2009 Sep; 9(5):368-76. PubMed ID: 19664366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of natural products for the treatment of Alzheimer's disease.
    Noori T; Dehpour AR; Sureda A; Sobarzo-Sanchez E; Shirooie S
    Eur J Pharmacol; 2021 May; 898():173974. PubMed ID: 33652057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis.
    Liu R; Wu CX; Zhou D; Yang F; Tian S; Zhang L; Zhang TT; Du GH
    BMC Med; 2012 Sep; 10():105. PubMed ID: 22989295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
    Han J; Du Z; Lim MH
    Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Alzheimer's disease drug development.
    Rafii MS; Aisen PS
    BMC Med; 2015 Mar; 13():62. PubMed ID: 25857341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current therapeutic strategy in Alzheimer's disease.
    Singh S; Kushwah AS; Singh R; Farswan M; Kaur R
    Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1651-64. PubMed ID: 23161037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
    Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches for the treatment of Alzheimer's disease.
    Fish PV; Steadman D; Bayle ED; Whiting P
    Bioorg Med Chem Lett; 2019 Jan; 29(2):125-133. PubMed ID: 30501965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem Cell Therapies in Alzheimer's Disease: Applications for Disease Modeling.
    Si Z; Wang X
    J Pharmacol Exp Ther; 2021 May; 377(2):207-217. PubMed ID: 33558427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer's Disease.
    Kang YJ; Diep YN; Tran M; Cho H
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients.
    Panza F; Seripa D; Solfrizzi V; Imbimbo BP; Lozupone M; Leo A; Sardone R; Gagliardi G; Lofano L; Creanza BC; Bisceglia P; Daniele A; Bellomo A; Greco A; Logroscino G
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):377-391. PubMed ID: 27678025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of HMGB1, RAGE, and TLR4 in Alzheimer's Disease (AD): From Risk Factors to Therapeutic Targeting.
    Paudel YN; Angelopoulou E; Piperi C; Othman I; Aamir K; Shaikh MF
    Cells; 2020 Feb; 9(2):. PubMed ID: 32046119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel disease-modifying therapies for Alzheimer's disease.
    Jiang T; Yu JT; Tan L
    J Alzheimers Dis; 2012; 31(3):475-92. PubMed ID: 22669013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.